Published Date: 
Total Pages: 
Report Id: BPFM717

Blood plasma fractionation insinuates the general strategies of disconnecting the distinctive parts of blood plasma, which in this way is a portion of blood got past blood fractionation. The plasma fractionation industry is an area of the Biopharmaceutical business in which the plasma segment of human blood is handled to extricate helpful items. The business is moderately developed, with the center plasma fractionation innovation unaltered. Factors, for example, developing maturing populace, rising rates of draining and insusceptible issue, and developing utilization of immunoglobulin and alpha-1-antitrypsin are the essential development drivers for the worldwide plasma fractionation market.


How Big is The Global Plasma Fractionation Market?


The Global Plasma Fractionation Market is expected to exceed more than US$ 25.97 Billion by 2022 at a CAGR of 6.7% in the given forecast period.


The major driving factors of Global Plasma Fractionation Market are as follows:


  • Increasing use of immunoglobulin in various therapeutic areas
  • Growth in the aging population across the globe
  • Growth in Number of Hemophilic Patients
  • Developing occurrence of respiratory diseases & AATD driving the uptake of alpha-1 antitrypsin
  • Growth in plasma collection


The restraining factors of Global Plasma Fractionation Market are as follows:


  • High cost and limited reimbursements
  • Strict government regulations
  • Pressure of pricing faced by prominent players in the market
  • Emergence of recombinant alternatives


The Global Plasma Fractionation Market is segmented on the lines of its product, application, end user and regional. Based on product segmentation it covers albumin, immunoglobulin, coagulation factor concentrates, protease inhibitors, other plasma fractionation products. Based on application segmentation it covers neurology, immunology, hematology, haemato-oncology, pulmonology, rheumatology, critical care, others. Based on end user segmentation it covers hospitals and clinics, clinical research laboratories, academic institutes. The Global Plasma Fractionation Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.


This report provides:
1) An overview of the global market for Global Plasma Fractionation Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Plasma Fractionation Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.



The scope of the report includes a detailed study of global and regional markets on Global Plasma Fractionation Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), China Biologic Products, Inc. (China), Biotest AG (Germany), LFB S.A (France), Bio Product Laboratory Ltd. (U.K.), and Sanquin (Netherlands). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.


The Global Plasma Fractionation Market has been segmented as below:


By Product Analysis:

  • Albumin
  • Immunoglobulin
    • Intravenous Immunoglobulin
    • Subcutaneous Immunoglobulin
    • Others
  • Coagulation Factor Concentrates
    • Factor VIII
    • Factor IX
    • Factor XIII
    • Prothrombin Complex Concentrates
    • Von Willebrand Factor (VWF)
  • Protease Inhibitors
  • Other Plasma Fractionation Products


By Application Analysis:

  • Neurology
  • Immunology
  • Haematology
  • Haemato-oncology
  • Pulmonology
  • Rheumatology
  • Critical Care
  • Others


By End User Analysis:

  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes


By Regional Analysis:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World


Reasons to Buy this Report:
1) Obtain the most up to date information available on all  Global Plasma Fractionation Market .
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Plasma Fractionation Market data.
4) Assess your competitor’s refining portfolio and its evolution.


We can offer you custom research reports as per client’s special requirements.

    1.1    KEY TAKE AWAYS    
    1.3    MARKETS COVERED    
    1.4    STAKEHOLDERS    
    1.5.1    MARKET SIZE    
    1.5.2    MARKET SHARE    

2 Research Methodology 
    2.1 Research Approach 
           2.1.1 Secondary Sources
           2.1.2 Key Data From Secondary Sources
           2.1.3 Primary Sources
           2.1.4 Key Data From Primary Sources
           2.1.5 Key Industry Insights
    2.2 Market Size Estimation 
    2.3 Market Breakdown and Data Triangulation 
    2.4 Market Share Estimation

3 Executive Summary 

4 Premium Insights 
    4.1 Market Overview 
    4.2 Asia-Pacific Plasma Fractionation Market 
    4.3 Plasma Fractionation Market: Geographic Growth Opportunities 
    4.4 Plasma Fractionation Market: Geographic Mix 
    4.5 Plasma Fractionation Market: Developing vs Developed Countries

5 Market Overview 
    5.1 Introduction 
    5.2 Market Dynamics 
    5.3 Key Market Drivers 
           5.3.1 Growing Use of Immunoglobulins in Various Therapeutic Areas
           5.3.2 Rise in the Aging Population Across the Globe
           5.3.3 Growing Prevalence of Respiratory Diseases and Aatd Driving the Uptake of Alpha-1 Antitrypsin
           5.3.4 Increase in Plasma Collection
    5.4 Key Market Restraints 
           5.4.1 High Cost and Limited Reimbursements
           5.4.2 Stringent Government Regulations
           5.4.3 Emergence of Recombinant Alternatives
    5.5 Key Market Opportunities 
           5.5.1 Increasing Number of Hemophilic Patients
    5.6 Key Challenges 
           5.6.1 Pricing Pressure Faced By Prominent Players in the Market

6 Industry Insights 
    6.1 Introduction 
    6.2 Key Industry Trends 
           6.2.1 Focus on Increasing Fractionation CAPACities and Geographical Expansions
           6.2.2 New Indications for Plasma Products
           6.2.3 Rising Adoption of SCIG
           6.2.4 Increasing Number of Fractionator-Owned Plasma Collection Centers
           6.2.5 Growing Plasma Products Market in China
           6.2.6 Increasing Focus of Plasma Fractionators Towards Manufacturing and Development of Recombinant Factors
    6.3 Porter’s Five Forces Analysis 
           6.3.1 Threat of New Entrants
           6.3.2 Threat of Substitutes
           6.3.3 Bargaining Power of Suppliers
           6.3.4 Bargaining Power of Buyers
           6.3.5 Intensity of Competitive Rivalry

7 Global Plasma Fractionation Market, By Product 
    7.1 Introduction 
    7.2 Fractionation Process 
    7.3 Immunoglobulin 
           7.3.1 Intravenous Immunoglobulin
           7.3.2 Subcutaneous Immunoglobulin
           7.3.3 Other Immunoglobulins
    7.4 Coagulation Factor Concentrates 
           7.4.1 Factor VIII
           7.4.2 Factor IX
           7.4.3 Factor XIII
           7.4.4 Prothrombin Complex Concentrates
           7.4.5 Von Willebrand Factor (VWF)
           7.4.6 Fibrinogen Concentrates
    7.5 Albumin 
    7.6 Protease Inhibitors 
    7.7 Other Plasma Products

8 Global Plasma Fractionation Market, By Application 
    8.1 Introduction 
    8.2 Neurology 
    8.3 Immunology 
    8.4 Hematology 
    8.5 Critical Care 
    8.6 Pulmonology 
    8.7 Hemato-Oncology 
    8.8 Rheumatology 
    8.9 Other Applications

9 Global Plasma Fractionation Market, By End User 
    9.1 Introduction 
    9.2 Hospitals and Clinics 
    9.3 Clinical Research Laboratories 
    9.4 Academic Institutes

10 Global Plasma Fractionation Market, By Region 
     10.1 Introduction 
     10.2 North America 
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe 
             10.3.1 Germany
             10.3.2 France
             10.3.3 Italy
             10.3.4 Spain
             10.3.5 U.K.
             10.3.6 Rest of Europe (RoE)
     10.4 Asia-Pacific 
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 Rest of Asia-Pacific (Ro-APAC)
     10.5 Rest of the World (RoW) 
             10.5.1 Latin America
             10.5.2 Middle East and Africa

11 Competitive Landscape 
     11.1 Overview 
     11.2 Market Share Analysis 
     11.3 Competitive Situation and Trends 
             11.3.1 Expansions
             11.3.2 Agreements, Collaborations, and Partnerships
             11.3.3 New Product Launches
             11.3.4 Acquisitions

License Format Properties
Single User License The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Multi User License The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user license, allowing up to five users to have access to the product.
Corporate License The report will be emailed to you. The report is sent in PDF format. This is a 10+ user license, allowing up to 10+ users to have access to the product.
Mini Report License In this you will receive full report except the Company Profile section of this report. In this you will receive full report except the Company Profile section of this report.
Need More Information: 


Toll Free No. : +1-855-984-1862

Call Us. : +91 86 05 657204